Genes and structure of selected cytokines involved in pathogenesis of psoriasis.

Psoriasis is a common skin disease involving 1-4% of human population worldwide, of strong genetic background. The following cytokines are directly involved in psoriasis: TNF, IL-1, IL-2, IL-6, IL-7, IL-8, IL-15, IL-18, IL-19, IL-20, IL-23 whereas IL-4, IL-10, IL-12 as well as IL-11, IL-17 and IFN-gamma are rather indirectly engaged. This work is a review of some genetic factors and structure of selected cytokines and receptors and their genes location.

[1]  T. Kupper,et al.  Cytokines: IL-20 — a new effector in skin inflammation , 2001, Current Biology.

[2]  S. Kotenko,et al.  Interleukin 24 (MDA-7/MOB-5) Signals through Two Heterodimeric Receptors, IL-22R1/IL-20R2 and IL-20R1/IL-20R2* , 2002, The Journal of Biological Chemistry.

[3]  A. Bowcock,et al.  Gene for familial psoriasis susceptibility mapped to the distal end of human chromosome 17q. , 1994, Science.

[4]  T. Taniguchi,et al.  The IL-2 receptor complex: its structure, function, and target genes. , 1993, Annual review of immunology.

[5]  M. Suarez‐Almazor,et al.  The genetics of psoriasis. Haplotype sharing in siblings with the disease. , 1990, Archives of dermatology.

[6]  R. Horuk.  The interleukin-8-receptor family: from chemokines to malaria. , 1994, Immunology today.

[7]  M. Gately,et al.  Expression cloning of a human IL-12 receptor component. A new member of the cytokine receptor superfamily with strong homology to gp130. , 1994, Journal of immunology.

[8]  J. Vilček,et al.  Interleukin 6: a multifunctional cytokine regulating immune reactions and the acute phase protein response. , 1989, Laboratory investigation; a journal of technical methods and pathology.

[9]  D. Williams,et al.  Interleukin-11: review of molecular, cell biology, and clinical use. , 1997, Blood.

[10]  H. Tagami,et al.  Interleukin 2, soluble interleukin 2 receptor, and interferon-γ in the suction blister fluids from psoriatic skin , 2004, Archives of Dermatological Research.

[11]  M. Boniotto,et al.  Human interleukin-19 and its receptor: a potential role in the induction of Th2 responses. , 2002, International immunopharmacology.

[12]  E. Wagner,et al.  Psoriasis-like skin disease and arthritis caused by inducible epidermal deletion of Jun proteins , 2005, Nature.

[13]  R. S. Rogers.  Genetics of psoriasis. , 1975, Minnesota medicine.

[14]  S. Kõks,et al.  Combined haplotype analysis of the interleukin-19 and -20 genes: relationship to plaque-type psoriasis , 2004, Genes and Immunity.

[15]  S. Pestka,et al.  Cloning, expression and initial characterisation of interleukin-19 (IL-19), a novel homologue of human interleukin-10 (IL-10) , 2000, Genes and Immunity.

[16]  J. Kere,et al.  Psoriasis susceptibility locus on 18p revealed by genome scan in Finnish families not associated with PSORS1. , 2003, The Journal of investigative dermatology.

[17]  Daniel B. Shin,et al.  Risk of myocardial infarction in patients with psoriasis. , 2006, JAMA.

[18]  F. Nestle,et al.  Recent insights into the immunopathogenesis of psoriasis provide new therapeutic opportunities. , 2004, The Journal of clinical investigation.

[19]  K. Frazer,et al.  Computational and biological analysis of 680 kb of DNA sequence from the human 5q31 cytokine gene cluster region. , 1997, Genome research.

[20]  James T. Elder,et al.  Meta-analysis of genome-wide studies of psoriasis susceptibility reveals linkage to chromosomes 6p21 and 4q28-q31 in Caucasian and Chinese Hans population. , 2004, The Journal of investigative dermatology.

[21]  A. Mercer,et al.  A homolog of interleukin-10 is encoded by the poxvirus orf virus , 1997, Journal of virology.

[22]  James T. Elder,et al.  Localization of psoriasis-susceptibility locus PSORS1 to a 60-kb interval telomeric to HLA-C. , 2000, American journal of human genetics.

[23]  K. Asadullah,et al.  Interleukin-10: an important immunoregulatory cytokine with major impact on psoriasis. , 2004, Current drug targets. Inflammation and allergy.

[24]  H. Sticht,et al.  The interleukin-10 family of cytokines. , 2002, Trends in immunology.

[25]  F. Dumont.  IL-17 cytokine/receptor families: emerging targets for the modulation of inflammatory responses , 2003 .

[26]  M. Yamamura,et al.  The cytokine network in lesional and lesion-free psoriatic skin is characterized by a T-helper type 1 cell-mediated response. , 1993, The Journal of investigative dermatology.

[27]  J. Bazan,et al.  Haemopoietic receptors and helical cytokines. , 1990, Immunology today.

[28]  J. Szepietowski,et al.  Increased interleukin‐7 levels in the sera of psoriatic patients: lack of correlations with interleukin‐6 levels and disease intensity , 2000, Clinical and experimental dermatology.

[29]  James T. Elder,et al.  Evidence for two psoriasis susceptibility loci (HLA and 17q) and two novel candidate regions (16q and 20p) by genome-wide scan. , 1997, Human molecular genetics.

[30]  Kendall A. Smith,et al.  Heterogeneity of human T-cell growth factor(s) due to variable glycosylation. , 1981, Molecular immunology.

[31]  J. Clausen,et al.  The dynamics of gene expression of interleukin‐19 and interleukin‐20 and their receptors in psoriasis , 2005, The British journal of dermatology.

[32]  D. Gudbjartsson,et al.  A susceptibility gene for psoriatic arthritis maps to chromosome 16q: evidence for imprinting. , 2003, American journal of human genetics.

[33]  T. Moseley,et al.  Interleukin-17 family and IL-17 receptors. , 2003, Cytokine & growth factor reviews.

[34]  D. West,et al.  Biologic therapy for psoriasis: the new therapeutic frontier. , 2002, Archives of dermatology.

[35]  W. Fiers,et al.  Two tumour necrosis factor receptors: structure and function. , 1995, Trends in cell biology.

[36]  Khusru Asadullah,et al.  Biology of tumor necrosis factor‐α– implications for psoriasis , 2004, Experimental dermatology.

[37]  J. Sims.  IL-1 and IL-18 receptors, and their extended family. , 2002, Current opinion in immunology.

[38]  Li Jin,et al.  Evidence for a major psoriasis susceptibility locus at 6p21(PSORS1) and a novel candidate region at 4q31 by genome-wide scan in Chinese hans. , 2002, The Journal of investigative dermatology.

[39]  C. Wernicke,et al.  Genomic structure and chromosomal localization of the human interleukin 15 gene (IL-15). , 1996, Cytokine.

[40]  R. Kurzrock.  Interleukin-4 and Interleukin-13 , 2003 .

[41]  A. Wojas-Pelc,et al.  Cytokine network in psoriasis. Cross-talk between keratinocytes and cells of the skin immune system , 2006 .

[42]  A. Menssen,et al.  T lymphocytes derived from skin lesions of patients with psoriasis vulgaris express a novel cytokine pattern that is distinct from that of T helper type 1 and T helper type 2 cells , 1994, European journal of immunology.

[43]  E. McMullen,et al.  Physical friction is under‐recognized as an irritant that can cause or contribute to contact dermatitis , 2006, The British journal of dermatology.

[44]  G. Trinchieri,et al.  Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes , 1989, Journal of Experimental Medicine.

[45]  Giorgio,et al.  Production of natural killer cell stimulatory factor (interleukin 12) by peripheral blood mononuclear cells , 1992, The Journal of experimental medicine.

[46]  C. Stansberg,et al.  The interleukin 1 receptor family. , 2004, Developmental and comparative immunology.

[47]  K. Madden,et al.  Interleukins 19, 20, and 24 Signal through Two Distinct Receptor Complexes , 2002, The Journal of Biological Chemistry.

[48]  A. Lindén,et al.  Interleukin-17 family members and inflammation. , 2004, Immunity.

[49]  T. Mcclanahan,et al.  A Receptor for the Heterodimeric Cytokine IL-23 Is Composed of IL-12Rβ1 and a Novel Cytokine Receptor Subunit, IL-23R1 , 2002, The Journal of Immunology.

[50]  L. Naldi,et al.  Dietary factors and the risk of psoriasis. Results of an Italian case–control study , 1996, The British journal of dermatology.

[51]  R. de Waal Malefyt,et al.  Interleukin-17 and interferon-gamma synergize in the enhancement of proinflammatory cytokine production by human keratinocytes. , 1998, The Journal of investigative dermatology.

[52]  A. Blauvelt.  In This Issue—Full Court Press on Psoriasis , 2004 .

[53]  A. L. Goldstein,et al.  Recent advances in the understanding of the biochemistry and clinical pharmacology of interleukin-2. , 1987, Lymphokine research.

[54]  R. Dubose,et al.  Identification and cloning of a novel IL‐15 binding protein that is structurally related to the alpha chain of the IL‐2 receptor. , 1995, The EMBO journal.

[55]  A. Wlodawer,et al.  Corrigendum to “Crystal structure of human recombinant interleukin‐4 at 2.25 Å resolution” [FEBS Lett. 309 (1992) 59–64] , 2006 .

[56]  J. Browne,et al.  Identification of a major susceptibility locus on chromosome 6p and evidence for further disease loci revealed by a two stage genome-wide search in psoriasis. , 1997, Human molecular genetics.

[57]  J. Wahlström,et al.  A population genetic study of psoriasis , 1994, Acta dermato-venereologica. Supplementum.

[58]  E. Christophers,et al.  Psoriasis of early and late onset: characterization of two types of psoriasis vulgaris. , 1985, Journal of the American Academy of Dermatology.

[59]  S. Plevy,et al.  The interleukin-12 family of cytokines: Therapeutic targets for inflammatory disease mediation , 2005 .

[60]  A. Gustchina,et al.  Crystal structure of human recombinant interleukin‐4 at 2.25 Å resolution , 1992, FEBS letters.

[61]  T. Waldmann,et al.  Identification of a novel receptor/signal transduction pathway for IL‐15/T in mast cells , 1996, The EMBO journal.

[62]  T. Wienker,et al.  Genomewide scan in german families reveals evidence for a novel psoriasis-susceptibility locus on chromosome 19p13. , 2000, American journal of human genetics.

[63]  James T. Elder,et al.  The genetics of psoriasis. , 1994, Journal of the American Academy of Dermatology.

[64]  J. Trent,et al.  Chromosomal localization of human leukocyte, fibroblast, and immune interferon genes by means of in situ hybridization. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[65]  D. Tillman,et al.  Genetics of psoriasis: paternal inheritance and a locus on chromosome 6p. , 1998, The Journal of investigative dermatology.

[66]  Y. Yang,et al.  Genomic sequence and chromosomal location of human interleukin-11 gene (IL11). , 1992, Genomics.

[67]  M. Gately,et al.  Human IL-12 p40 homodimer binds to the IL-12 receptor but does not mediate biologic activity. , 1995, Journal of immunology.

[68]  L. Old,et al.  Tumor necrosis factor (TNF). , 1985, Science.

[69]  D. Le Paslier,et al.  The gene coding for interferon-gamma is linked to the D12S335 and D12S313 microsatellites and to the MDM2 gene. , 1995, Genomics.

[70]  W. Fanslow,et al.  Human IL-17: a novel cytokine derived from T cells. , 1995, Journal of immunology.

[71]  S. Ziegler,et al.  Interleukin-2 receptor gamma chain: a functional component of the interleukin-7 receptor. , 1993, Science.

[72]  K. Asadullah,et al.  Interleukin-10 in cutaneous disorders: implications for its pathophysiological importance and therapeutic use , 1999, Archives of Dermatological Research.

[73]  J. Gudjonsson,et al.  Immunopathogenic mechanisms in psoriasis , 2004, Clinical and experimental immunology.

[74]  Simon MacKenzie,et al.  Tumor necrosis factors. , 2004, Developmental and comparative immunology.

[75]  G. Chodorowska.  Plasma concentrations of IFN‐γ and TNF‐α: in psoriatic patients before and after local treatment with dithranol ointment , 1998 .

[76]  D. P. Murphy,et al.  Interleukin 6 is expressed in high levels in psoriatic skin and stimulates proliferation of cultured human keratinocytes. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[77]  S. Sonis,et al.  IL-11, a pleiotropic cytokine: exciting new effects of IL-11 on gastrointestinal mucosal biology. , 1994, Stem cells.

[78]  David A. Williams,et al.  Interleukin-11: a multifunctional growth factor derived from the hematopoietic microenvironment. , 1994, Blood.

[79]  R. Trembath,et al.  Identification of a novel psoriasis susceptibility locus at 1p and evidence of epistasis between PSORS1 and candidate loci , 2001, Journal of medical genetics.

[80]  M. FitzGerald,et al.  A sequence-based map of the nine genes of the human interleukin-1 cluster. , 2002, Genomics.

[81]  M. Meltzer,et al.  Tumor necrosis factor. , 1991, Journal of the American Academy of Dermatology.

[82]  M. Zago,et al.  The Profile of Gene Expression of Human Marrow Mesenchymal Stem Cells , 2003, Stem cells.

[83]  James T. Elder.  Fine mapping of the psoriasis susceptibility gene PSORS1: a reassessment of risk associated with a putative risk haplotype lacking HLA-Cw6. , 2005, The Journal of investigative dermatology.

[84]  J. Warrington,et al.  Assignment of genes encoding a unique cytokine (IL12) composed of two unrelated subunits to chromosomes 3 and 5. , 1992, Genomics.

[85]  K. Arai,et al.  Sharing of the interleukin-2 (IL-2) receptor gamma chain between receptors for IL-2 and IL-4. , 1993, Science.

[86]  M. Russo,et al.  What kind of message does IL-12/IL-23 bring to macrophages and dendritic cells? , 2004, Microbes and infection.

[87]  R. Kastelein,et al.  Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain , 2003, Nature.

[88]  G. Krueger,et al.  Epidemiology of psoriasis: clinical issues. , 1994, The Journal of investigative dermatology.

[89]  K. Książek,et al.  Interleukin-17: a mediator of inflammatory responses , 2004, Cellular and Molecular Life Sciences CMLS.

[90]  A Wlodawer,et al.  Crystal structure of interleukin-10 reveals the functional dimer with an unexpected topological similarity to interferon gamma. , 1995, Structure.

[91]  S. Swain,et al.  Interleukin 18 , 2001, The Journal of experimental medicine.

[92]  R. Vaughan,et al.  A non-HLA gene within the MHC in psoriasis , 1999, The Lancet.

[93]  H. E. Hansen,et al.  Psoriasis in monozygotic twins: variations in expression in individuals with identical genetic constitution. , 1982, Acta dermato-venereologica.

[94]  J. Banchereau,et al.  The Primary Binding Subunit of the Human Interleukin-4 Receptor Is Also a Component of the Interleukin-13 Receptor (*) , 1995, The Journal of Biological Chemistry.

[95]  Jie Zheng,et al.  Confirmation of PSORS psoriasis susceptibility loci in a Chinese population , 2003, Archives of Dermatological Research.

[96]  T. Mosmann,et al.  Expression of interleukin-10 activity by Epstein-Barr virus protein BCRF1. , 1990, Science.

[97]  M. Leach,et al.  Ubiquitous Transgenic Expression of the IL-23 Subunit p19 Induces Multiorgan Inflammation, Runting, Infertility, and Premature Death , 2001, The Journal of Immunology.

[98]  P. Schnitzler,et al.  Molecular characterization and determination of the coding capacity of the genome of equine herpesvirus type 2 between the genome coordinates 0.235 and 0.258 (theEcoRI DNA fragment N; 4.2 kbp) , 1994, Virus Genes.

[99]  A. Bowcock,et al.  The genetics of psoriasis: a complex disorder of the skin and immune system. , 1998, Human molecular genetics.

[100]  G. T. te Meerman,et al.  Haplotype sharing analysis identifies a retroviral dUTPase as candidate susceptibility gene for psoriasis. , 2005, Journal of Investigative Dermatology.

[101]  L. Samuelsson,et al.  Significantly earlier age at onset for the HLA-Cw6-positive than for the Cw6-negative psoriatic sibling. , 1997, The Journal of investigative dermatology.

[102]  D. Lejeune,et al.  Cutting Edge: STAT Activation By IL-19, IL-20 and mda-7 Through IL-20 Receptor Complexes of Two Types1 , 2001, The Journal of Immunology.

[103]  J. Giri.  Identification and cloning of a nobel IL - 15 binding protein that is strucurally related to the αchain of the IL - 2 receptor. , 1995 .

[104]  T. Kishimoto,et al.  The biology of interleukin-6. , 1989, Blood.

[105]  G. T. te Meerman,et al.  Evaluation of the IRF-2 gene as a candidate for PSORS3. , 2004, The Journal of investigative dermatology.

[106]  S. Menon,et al.  Crystal structure of Epstein-Barr virus protein BCRF1, a homolog of cellular interleukin-10. , 1997, Journal of molecular biology.

[107]  H. Yang,et al.  A functional interleukin 12 receptor complex is composed of two beta-type cytokine receptor subunits. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[108]  J Wagner,et al.  Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. , 2000, Immunity.

[109]  K. Torigoe,et al.  Purification and Characterization of the Human Interleukin-18 Receptor* , 1997, The Journal of Biological Chemistry.

[110]  D. Conklin,et al.  Interleukin 20 Discovery, Receptor Identification, and Role in Epidermal Function , 2001, Cell.

[111]  O. Shaker,et al.  The role of interleukin-12 in the pathogenesis of psoriasis. , 2006, Clinical biochemistry.

[112]  H. Mühl,et al.  Anti-inflammatory properties of pro-inflammatory interferon-gamma. , 2003, International immunopharmacology.

[113]  W. Arend,et al.  Biological role of interleukin 1 receptor antagonist isoforms , 2000, Annals of the rheumatic diseases.

[114]  J. Symons,et al.  Serum-soluble interleukin 2 receptor in psoriasis. Failure to reflect clinical improvement. , 1990, Acta dermato-venereologica.

[115]  J. Bos,et al.  Characterization of lesional psoriatic skin T lymphocyte clones. , 1994, Acta dermato-venereologica. Supplementum.

[116]  E. Fisher,et al.  Evidence that a locus for familial psoriasis maps to chromosome 4q , 1996, Nature Genetics.

[117]  T. Waldmann,et al.  The multifaceted regulation of interleukin-15 expression and the role of this cytokine in NK cell differentiation and host response to intracellular pathogens. , 1999, Annual review of immunology.

[118]  R. Paus,et al.  A promiscuous liaison between IL‐15 receptor and Axl receptor tyrosine kinase in cell death control , 2005, The EMBO journal.

[119]  N. Makhatadze.  Tumor necrosis factor locus: genetic organisation and biological implications. , 1998, Human immunology.

[120]  H. Okamura,et al.  Interleukin-18 regulates both Th1 and Th2 responses. , 2001, Annual review of immunology.

[121]  C. Dinarello,et al.  Biologic basis for interleukin-1 in disease. , 1996, Blood.

[122]  C. March,et al.  Human interleukin 4 receptor confers biological responsiveness and defines a novel receptor superfamily , 1990, The Journal of experimental medicine.

[123]  B. Dallapiccola,et al.  Searching for psoriasis susceptibility genes in Italy: genome scan and evidence for a new locus on chromosome 1. , 1999, The Journal of investigative dermatology.

[124]  James T. Elder,et al.  Epidemiology and the genetics of psoriasis. , 1994, The Journal of investigative dermatology.

[125]  N. Camp,et al.  Novel genetic association between the corneodesmosin (MHC S) gene and susceptibility to psoriasis. , 1999, Human molecular genetics.

[126]  C. Dinarello.  Interleukin 1 and interleukin 18 as mediators of inflammation and the aging process. , 2006, The American journal of clinical nutrition.

[127]  D. S. Garrett,et al.  Three-dimensional solution structure of human interleukin-4 by multidimensional heteronuclear magnetic resonance spectroscopy. , 1993, Science.

[128]  A. Bowcock,et al.  Psoriasis: genetic associations and immune system changes , 2007, Genes and Immunity.

[129]  J. Riley,et al.  Psoriasis susceptibility locus in chromosome region 3q21 identified in patients from southwest Sweden , 1999, European Journal of Human Genetics.

[130]  D. Cosman,et al.  Utilization of the beta and gamma chains of the IL‐2 receptor by the novel cytokine IL‐15. , 1994, The EMBO journal.

[131]  D. Aderka.  The potential biological and clinical significance of the soluble tumor necrosis factor receptors. , 1996, Cytokine & growth factor reviews.

[132]  W. Jochum,et al.  T cells involved in psoriasis vulgaris belong to the Th1 subset. , 1994, The Journal of investigative dermatology.

[133]  P. Nibbering,et al.  Psoriasis is not associated with IL-12p70/IL-12p40 production and IL12B promoter polymorphism. , 2004, The Journal of investigative dermatology.

[134]  Manuela Battaglia,et al.  Human CD25+CD4+ T Suppressor Cell Clones Produce Transforming Growth Factor β, but not Interleukin 10, and Are Distinct from Type 1 T Regulatory Cells , 2002, The Journal of experimental medicine.

[135]  S. Kõks,et al.  Polymorphisms in the interleukin-20 gene: relationships to plaque-type psoriasis , 2004, Genes and Immunity.

[136]  T. Henseler,et al.  Genetics of psoriasis , 1998, Archives of Dermatological Research.